AeroVironment Announces Fiscal 2024 First Quarter Results
ARLINGTON, Va.–(BUSINESS WIRE)–$AVAV—AeroVironment, Inc. (“AeroVironment” or the “Company”) reported today financial results for the fiscal…
ARLINGTON, Va.–(BUSINESS WIRE)–$AVAV—AeroVironment, Inc. (“AeroVironment” or the “Company”) reported today financial results for the fiscal…
FREMONT, Calif. & CLEARWATER, Fla.–(BUSINESS WIRE)–TD SYNNEX (NYSE: SNX) today announced it will report its…
GLENDALE, Calif.–(BUSINESS WIRE)–Public Storage (NYSE:PSA) announced today the launch of the Savvy Storage Insurance Program®…
Nucleome Therapeutics appoints Dr Russell Greig as Non–Executive Chair of the Board Dr Greig brings…
Nucleome Therapeutics appoints Dr Russell Greig as Non–Executive Chair of the Board Dr Greig brings…
VALNEVA Declaration of shares and voting rightsAugust 31, 2023__________________________________________________________________________________________ Company name: VALNEVARegistered office: 6 rue…
VALNEVA Declaration of shares and voting rightsAugust 31, 2023__________________________________________________________________________________________ Company name: VALNEVARegistered office: 6 rue…
Substantial reductions in rate and risk of exacerbations support potential of ensifentrine, an investigational, novel,…
Substantial reductions in rate and risk of exacerbations support potential of ensifentrine, an investigational, novel,…
TURKU, Finland and BOSTON, Sept. 06, 2023 (GLOBE NEWSWIRE) — Faron Pharmaceuticals Ltd. (AIM: FARN, First…
TURKU, Finland and BOSTON, Sept. 06, 2023 (GLOBE NEWSWIRE) — Faron Pharmaceuticals Ltd. (AIM: FARN, First…
Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today…
Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today…
After nearly seven years at Novartis and more than four years as a member of…
After nearly seven years at Novartis and more than four years as a member of…
Geneva, Switzerland, September 6, 2023 – Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical…
Ad hoc announcement pursuant to Art. 53 LR Aprocitentan, Idorsia’s oral, dual endothelin receptor antagonist…
Significant improvement towards profitability year over year Revenues from customers spending $5,000 or more grew…
OxyTap Pte Ltd launches OxyTap 5, a regenerative oxygen supplement infuser that increases oxygen levels…
New York, New York–(Newsfile Corp. – September 6, 2023) – Dime, the pioneering Gen Z…